| Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009 | 1401 | 2009 |
| Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff, K Buchacz, ... PloS one 8 (12), e81355, 2013 | 883 | 2013 |
| Workshop on HIV infection and aging: what is known and future research directions RB Effros, CV Fletcher, K Gebo, JB Halter, WR Hazzard, FMF Horne, ... Clinical infectious diseases: an official publication of the Infectious …, 2008 | 539 | 2008 |
| The lifetime cost of current human immunodeficiency virus care in the United States BR Schackman, KA Gebo, RP Walensky, E Losina, T Muccio, PE Sax, ... Medical care, 990-997, 2006 | 532 | 2006 |
| HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. KP High, M Brennan-Ing, DB Clifford, MH Cohen, J Currier, SG Deeks, ... Journal of acquired immune deficiency syndromes (1999) 60 (Suppl 1), S1-18, 2012 | 414 | 2012 |
| Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America MJ Silverberg, B Lau, AC Justice, E Engels, MJ Gill, JJ Goedert, GD Kirk, ... Clinical infectious diseases 54 (7), 1026-1034, 2012 | 386 | 2012 |
| Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic GM Lucas, KA Gebo, RE Chaisson, RD Moore Aids 16 (5), 767-774, 2002 | 352 | 2002 |
| Role of liver biopsy in management of chronic hepatitis C: a systematic review KA Gebo, HF Herlong, MS Torbenson, MW Jenckes, G Chander, ... Hepatology 36 (S1), S161-S172, 2002 | 317 | 2002 |
| Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001 KA Gebo, JA Fleishman, R Conviser, ED Reilly, PT Korthuis, RD Moore, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (1), 96-103, 2005 | 310 | 2005 |
| Late presentation for human immunodeficiency virus care in the United States and Canada KN Althoff, SJ Gange, MB Klein, JT Brooks, RS Hogg, RJ Bosch, ... Clinical infectious diseases 50 (11), 1512-1520, 2010 | 250 | 2010 |
| Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of … E Losina, BR Schackman, SN Sadownik, KA Gebo, RP Walensky, ... Clinical Infectious Diseases 49 (10), 1570-1578, 2009 | 210 | 2009 |
| Neurosyphilis in a clinical cohort of HIV-1-infected patients KG Ghanem, RD Moore, AM Rompalo, EJ Erbelding, JM Zenilman, ... AIDS (London, England) 22 (10), 1145, 2008 | 207 | 2008 |
| Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review KA Gebo, G Chander, MW Jenckes, KG Ghanem, HF Herlong, ... Hepatology 36 (5B), s84-s92, 2002 | 187 | 2002 |
| Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals JL Long, EA Engels, RD Moore, KA Gebo AIDS (London, England) 22 (4), 489, 2008 | 182 | 2008 |
| HIV infection and older Americans: the public health perspective JT Brooks, K Buchacz, KA Gebo, J Mermin American journal of public health 102 (8), 1516-1526, 2012 | 181 | 2012 |
| Treatment of chronic hepatitis C: a systematic review G Chander, MS Sulkowski, MW Jenckes, MS Torbenson, HF Herlong, ... Hepatology 36 (5B), s135-s144, 2002 | 180 | 2002 |
| Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002 JA Fleishman, KA Gebo, ED Reilly, R Conviser, WC Mathews, PT Korthuis, ... Medical care, III40-III52, 2005 | 176 | 2005 |
| Contemporary costs of HIV health care in the HAART era KA Gebo, JA Fleishman, R Conviser, J Hellinger, FJ Hellinger, ... AIDS (London, England) 24 (17), 2705, 2010 | 174 | 2010 |
| Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults KN Althoff, KA McGinnis, CM Wyatt, MS Freiberg, C Gilbert, KK Oursler, ... Clinical Infectious Diseases 60 (4), 627-638, 2014 | 173* | 2014 |
| Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy GM Lucas, M Griswold, KA Gebo, J Keruly, RE Chaisson, RD Moore American journal of epidemiology 163 (5), 412-420, 2006 | 164 | 2006 |
